Dongwon F&B, a subsidiary of Dongwon Industries, introduces a 100% plant-based canned ham, expanding their My Plant Original lineup and marking a significant stride in the vegetable protein movement.
Dongwon F&B said that through its latest plant-based ham product, it is gearing up to become a total protein provider, especially to vegetarians. Moreover, the company is launching this meat alternative while moving towards the popularization of vegetable-based protein options.
As per The Korea Times, Dongwon F&B said this is the company's third plant-based food item added to its My Plant brand. Previously, it created dumplings and tuna-flavored food without any meat ingredients. These were introduced in March this year.
The My Plant Original canned ham is 100% plant-based, meaning it was made with pure vegetable ingredients. It has no cholesterol and offers the lowest calories compared to rival products in the South Korean market.
Also, compared to Dongwon F&B's Richam luncheon meat, My Plant version's calories are less than 40%. With only 175kcal per 100 grams, it has the lowest calories among the domestic canned hams sold in the country.
"We are promoting various forms of collaboration with different companies based on our competitiveness in mass production infrastructure and independent technology for canned ham products," an official of Dongwon F&B said in a statement. "We will lead the popularization of meat alternatives by targeting overseas markets with our export infrastructure."
Korea's Daily Impact reported that to produce the My Plant Original meat alternative, Dongwon F&B combined technology and the know-how it accumulated in more than 20 years while producing its Recham ham products.
Finally, the company did not just manufacture a plain plant-based canned ham, but Dongwon F&B ensured the product also conforms to the healthy diet trend. With this said, My Plant Ham is perfect for health-conscious customers, too.
Photo by: Julia Fiander/Unsplash


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Instagram Outage Disrupts Thousands of U.S. Users
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Parents abused by their children often suffer in silence – specialist therapy is helping them find a voice
The pandemic is still disrupting young people’s careers
Yes, government influences wages – but not just in the way you might think 



